Djillali Annane to Hydroxychloroquine
This is a "connection" page, showing publications Djillali Annane has written about Hydroxychloroquine.
Connection Strength
0.050
-
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. Int J Antimicrob Agents. 2020 Oct; 56(4):106129.
Score: 0.039
-
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
Score: 0.010